Published on
May 8, 2025
- 10:00 GMT
NeuroGenesis Awarded Grant from National MS Society’s Fast Forward Program to Advance Cell Therapy & Phase IIb Trial
NeuroGenesis has been awarded a grant from the National MS Society to advance its NG01 cell therapy and launch its Phase IIb trial for secondary progressive MS. ROCHESTER, NY, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- NeuroGenesis, a clinical- …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
